Evonik Industries has confirmed around 2,000 job losses 2026 due to a poor financial situation.
The German chemicals company plans to streamline operations and cut costs amid a stagnant market outlook, not anticipating an economic turnaround within the year.
Evonik aims to achieve annual cost savings of approximately 400 million euros ($433.6 million) by the end of 2026.
The restructuring plan disproportionately affects management positions, particularly in Germany.
Evonik’s decision underscores a growing trend among European chemical firms to tighten their belts in the face of persistent challenges.
It includes a weak demand and historically high energy costs, which prompted several industry players to issue profit warnings last year.
Other companies have echoed the sector’s cost-cutting measures.
BASF announced a billion-euro cost reduction at its Ludwigshafen site.
Need Career Advice? Get employment skills advice at all levels of your career
Similarly, Celanese plans to shut down a facility in Belgium, and Covestro focuses on cost efficiency and high-margin products.
Evonik’s CEO, Christian Kullmann, said: “The many crises around the world have put a damper on our results.”
Evonik announced the sale of its superabsorbents business to the International Chemical Investors Group, marking a significant step in divesting its performance-materials division.
This deal includes five production sites in Germany and the US, with the transaction expected to close by mid-2024.
